This topic contains a solution. Click here to go to the answer

Author Question: A governmental entity has a General Fund and an Enterprise Fund. At the beginning of the year, ... (Read 131 times)

erika

  • Hero Member
  • *****
  • Posts: 522
A governmental entity has a General Fund and an Enterprise Fund. At the beginning of the year, neither fund has any unpaid salary liability. During the year, both funds paid salaries of 600,000 .
 
  In addition, salaries for the last three days of the fiscal year (15,000 for each fund) will be paid during the first week of the next fiscal year. How much should each fund report as salary expenditures (expenses) for the fiscal year?
   General Enterprise
   Fund Fund
   a. 600,000 615,000
   b. 600,000 600,000
   c. 615,000 600,000
   d. 615,000 615,000

Question 2

A(n) ___________________ ___________ service acts as the EDI post office.
 Fill in the blank(s) with correct word



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

lolol

  • Sr. Member
  • ****
  • Posts: 330
Answer to Question 1

d

Answer to Question 2

value-added network (VAN)
value-added network
VAN




erika

  • Member
  • Posts: 522
Reply 2 on: Jul 5, 2018
Wow, this really help


jordangronback

  • Member
  • Posts: 339
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

In 2010, opiate painkllers, such as morphine, OxyContin®, and Vicodin®, were tied to almost 60% of drug overdose deaths.

Did you know?

Serum cholesterol testing in adults is recommended every 1 to 5 years. People with diabetes and a family history of high cholesterol should be tested even more frequently.

Did you know?

Excessive alcohol use costs the country approximately $235 billion every year.

Did you know?

Elderly adults are living longer, and causes of death are shifting. At the same time, autopsy rates are at or near their lowest in history.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library